144 related articles for article (PubMed ID: 20549003)
1. Host-virus interactions during hepatitis C virus infection: a complex and dynamic molecular biosystem.
Pezacki JP; Singaravelu R; Lyn RK
Mol Biosyst; 2010 Jul; 6(7):1131-42. PubMed ID: 20549003
[TBL] [Abstract][Full Text] [Related]
2. A Hepatitis C virus-host interaction involved in viral replication: toward the identification of antiviral targets.
Suzuki T
Jpn J Infect Dis; 2010 Sep; 63(5):307-11. PubMed ID: 20858994
[TBL] [Abstract][Full Text] [Related]
3. Network based analysis of hepatitis C virus core and NS4B protein interactions.
Tripathi LP; Kataoka C; Taguwa S; Moriishi K; Mori Y; Matsuura Y; Mizuguchi K
Mol Biosyst; 2010 Dec; 6(12):2539-53. PubMed ID: 20953506
[TBL] [Abstract][Full Text] [Related]
4. Primary cultures of human hepatocytes isolated from hepatitis C virus-infected cirrhotic livers as a model to study hepatitis C infection.
Raymond VA; Selliah S; Ethier C; Houle R; Jouan L; Maniere T; Lamarre D; Willems B; Bilodeau M
Liver Int; 2009 Jul; 29(6):942-9. PubMed ID: 19302183
[TBL] [Abstract][Full Text] [Related]
5. Virology and pathogenesis of hepatitis C virus recurrence.
Ramírez S; Pérez-Del-Pulgar S; Forns X
Liver Transpl; 2008 Oct; 14 Suppl 2():S27-35. PubMed ID: 18825723
[TBL] [Abstract][Full Text] [Related]
6. Proteomic analysis of hepatitis C virus (HCV) core protein transfection and host regulator PA28γ knockout in HCV pathogenesis: a network-based study.
Tripathi LP; Kambara H; Moriishi K; Morita E; Abe T; Mori Y; Chen YA; Matsuura Y; Mizuguchi K
J Proteome Res; 2012 Jul; 11(7):3664-79. PubMed ID: 22646850
[TBL] [Abstract][Full Text] [Related]
7. Host cell responses induced by hepatitis C virus binding.
Fang X; Zeisel MB; Wilpert J; Gissler B; Thimme R; Kreutz C; Maiwald T; Timmer J; Kern WV; Donauer J; Geyer M; Walz G; Depla E; von Weizsäcker F; Blum HE; Baumert TF
Hepatology; 2006 Jun; 43(6):1326-36. PubMed ID: 16729312
[TBL] [Abstract][Full Text] [Related]
8. [Molecular mechanisms of the hepatitis C virus, potential therapeutic targets].
Rivas-Estilla AM; Panduro A
Rev Invest Clin; 2003; 55(1):51-64. PubMed ID: 12708164
[TBL] [Abstract][Full Text] [Related]
9. The hepatitis C virus life cycle as a target for new antiviral therapies.
Pawlotsky JM; Chevaliez S; McHutchison JG
Gastroenterology; 2007 May; 132(5):1979-98. PubMed ID: 17484890
[TBL] [Abstract][Full Text] [Related]
10. Interplay between host cell and hepatitis C virus in regulating viral replication.
Bode JG; Brenndörfer ED; Karthe J; Häussinger D
Biol Chem; 2009 Oct; 390(10):1013-32. PubMed ID: 19642875
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis C virus triggers apoptosis of a newly developed hepatoma cell line through antiviral defense system.
Zhu H; Dong H; Eksioglu E; Hemming A; Cao M; Crawford JM; Nelson DR; Liu C
Gastroenterology; 2007 Nov; 133(5):1649-59. PubMed ID: 17983809
[TBL] [Abstract][Full Text] [Related]
12. Host factors involved in the replication of hepatitis C virus.
Moriishi K; Matsuura Y
Rev Med Virol; 2007; 17(5):343-54. PubMed ID: 17563922
[TBL] [Abstract][Full Text] [Related]
13. Pathophysiology of hepatitis C virus infection.
Camps J; Córdoba J; Esteban JI
Pathol Biol (Paris); 1995 Oct; 43(8):691-702. PubMed ID: 8745591
[TBL] [Abstract][Full Text] [Related]
14. Future options for the management of hepatitis C.
Davis GL; Nelson DR; Reyes GR
Semin Liver Dis; 1999; 19 Suppl 1():103-12. PubMed ID: 10349698
[TBL] [Abstract][Full Text] [Related]
15. Impact of steroids on hepatitis C virus replication in vivo and in vitro.
Henry SD; Metselaar HJ; Van Dijck J; Tilanus HW; Van Der Laan LJ
Ann N Y Acad Sci; 2007 Sep; 1110():439-47. PubMed ID: 17911459
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis A virus infection suppresses hepatitis C virus replication and may lead to clearance of HCV.
Deterding K; Tegtmeyer B; Cornberg M; Hadem J; Potthoff A; Böker KH; Tillmann HL; Manns MP; Wedemeyer H
J Hepatol; 2006 Dec; 45(6):770-8. PubMed ID: 17034895
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis C virus genetic variability in patients undergoing antiviral therapy.
Cristina J; del Pilar Moreno M; Moratorio G
Virus Res; 2007 Aug; 127(2):185-94. PubMed ID: 17449128
[TBL] [Abstract][Full Text] [Related]
18. Cellular and molecular biology of HCV infection and hepatitis.
Tang H; Grisé H
Clin Sci (Lond); 2009 Jun; 117(2):49-65. PubMed ID: 19515018
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis C virus entry.
Zeisel MB; Felmlee DJ; Baumert TF
Curr Top Microbiol Immunol; 2013; 369():87-112. PubMed ID: 23463198
[TBL] [Abstract][Full Text] [Related]
20. Existing and future therapeutic options for hepatitis C virus infection.
Bretner M
Acta Biochim Pol; 2005; 52(1):57-70. PubMed ID: 15827606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
